Ethicon Endo-Surgery Inc. is working to respond to FDA questions about follow-up data and training materials following receipt of a recent “approvable” letter for its Sedasys computer-assisted personalized sedation system, the company disclosed April 17 during its first-quarter earnings call.
The Johnson & Johnson subsidiary received the approvable letter in February, “and we need to respond to the requirements...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?